STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-06-14
Here’s whether DexCom, Inc. (DXCM) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.06% over 10 days); RSI 59 — healthy momentum range; 3-month momentum positive (+13.6%). Currently 16.2% off its 52-week high. Score: +6/7.
DXCM is in a confirmed uptrend, trading above both its 50-day ($65.87) and 200-day ($67.57) moving averages. An RSI of 58.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -9.0% compares to +22.9% for SPY (trailed the market by 31.9%).
$10,000 invested 1 year ago→ $9,097 today
vs. S&P 500 (SPY) — same period trailed market by 31.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($67.57)
✓Above 50-day MA ($65.87)
✓RSI(14) neutral zone (30–70) — currently 58.9
✗Positive return (-9.0%)
!Within 10% of period high (−16.2%)
Period Range $75.37
$54.11$89.98
RSI (14) 58.9
0 · OversoldOverbought · 100
Key Metrics
Price$75.37
Period Return-9.0%
Period High$89.98
Period Low$54.11
Drawdown−16.2%
MA-50$65.87
MA-200$67.57
RSI (14)58.9
Avg Volume (30d)6.8M
vs. SPYtrailed by 31.9%
Return Rank#774 of 1246
Trend Signals
Price is above the 200-day moving average ($67.57)